Can Melatonin Receptors Be Targeted for Therapeutic Purposes?
Yes, targeting melatonin receptors has therapeutic potential. Agonists and antagonists of melatonin receptors are being explored for treating various conditions, including insomnia, depression, and jet lag. Understanding the toxicological profile of these compounds is crucial to ensure their safety and efficacy. For example, the melatonin receptor agonist ramelteon is used to treat sleep disorders with a favorable safety profile.
